BridgeBio to Host Second Quarter 2025 Financial Results Conference Call on Tuesday, August 5, 2025 at 4:30 pm ET

Rhea-AI Summary

BridgeBio Pharma (Nasdaq: BBIO), a biopharmaceutical company specializing in genetic diseases, has scheduled its second quarter 2025 financial results conference call for Tuesday, August 5, 2025, at 4:30 pm ET. The company will release its financial results and business updates after market close on the same day.

Investors and interested parties can access the live webcast through BridgeBio's investor relations website. A replay will be available for 30 days following the event.

PALO ALTO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that it will release its second quarter financial results and business updates after the market closes on Tuesday, August 5, 2025. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day.

To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at investor.bridgebio.com/events-and-presentations/. A replay of the webcast will be available on the BridgeBio website for 30 days following the event.

Participants may access the webcast by registering online using the following link, https://events.q4inc.com/attendee/951604231.

About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn, Twitter, Facebook, and YouTube.

BridgeBio Media Contact:
Bubba Murarka, Executive Vice President, Corporate Development
contact@bridgebio.com  
(650)-789-8220

BridgeBio Investor Contact:
Chinmay Shukla, Senior Vice President, Strategic Finance
ir@bridgebio.com

FAQ

When will BridgeBio (BBIO) report Q2 2025 earnings?

BridgeBio will release its Q2 2025 financial results after market close on Tuesday, August 5, 2025, followed by a conference call at 4:30 pm ET.

How can I access BridgeBio's Q2 2025 earnings call?

Investors can access the live webcast by registering at the provided link or visiting the 'Events & Presentations' page on BridgeBio's investor relations website at investor.bridgebio.com.

How long will BridgeBio's Q2 2025 earnings call replay be available?

The webcast replay will be available on BridgeBio's website for 30 days following the event.

What is BridgeBio's stock symbol?

BridgeBio trades on the Nasdaq under the symbol BBIO.